Bausch & Lomb Escapes Class Claims in Suit Over Eye Supplement

A woman alleging Bausch & Lomb Inc.‘s PreserVision AREDS 2 supplement failed to warn users of the risk of excessive zinc intake improperly split her individual and class claims into parallel suits, a federal judge said.

The US District Court for the Northern District of California dismissed plaintiff Valerie Raskin’s proposed class action Thursday.

Raskin sued the eye health company after she was diagnosed with copper deficiency myelopathy. Her doctor told her that it was caused by the PreserVision supplement she took to prevent macular degeneration. Her class action complaint contained a single cause for a violation of California’s ...